(S029) Managing therapeutic anticoagulation in bariatric surgery patients

Shea, Brian; Motamedi, Seyed Mohammad Kalantar; Mustafa, Rami R.; Masnyj, Stephen; Sarode, Anuja L.; Abbas, Mujjahid; Khaitan, Leena

doi:10.1007/s00464-020-07958-x

Cited by 2 publications

(2 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The surgical procedures performed on the stomach and duodenum during bariatric surgery might impact the absorption of drugs, potentially leading to a reduction in the efficacy of LMWHs. 23 This effect poses a specific risk to patients with mechanical valves who rely on the anticoagulant properties of LMWHs.…”

Section: Metabolic Team Perspectivementioning

confidence: 99%

“…The chronic use of anticoagulants presents a significant challenge in planning bariatric surgeries for patients with class 2 and class 3 obesity. 23 Discontinuing chronic anticoagulant therapy before surgery is typically not feasible for patients with a prothrombogenic burden and prosthetic aortic valve, particularly mechanical valves. To minimize therapy interruption, recommendations propose considering therapeutic bridging for "high-risk" patients, such as those with atrial fibrillation or mechanical heart valves, during elective procedures.…”

Section: Importance Of Bariatric Surgery In Patients With Obesity And...mentioning

confidence: 99%

See 1 more Smart Citation

Optimizing aortic valve prosthesis selection in patients with obesity: Institutional experience with multidisciplinary perspective

Balkanay,

Bulut,

Albrahimi

et al. 2023

Asian Cardiovasc Thorac Ann

View full text Add to dashboard Cite

Background Aortic valve diseases are life-threatening conditions with increasing prevalence worldwide. Risk factors include gender, age, hypertension, dyslipidemia, and type 2 diabetes. Obesity is closely related to these risk factors and has been linked to a higher risk of developing aortic valve diseases. However, there is no specific guideline for managing aortic valve disease in patients with obesity, and the choice of valve type remains uncertain. Methods A total of 130 patients with obesity who met the inclusion criteria underwent surgical aortic valve replacement. The patients were divided into two groups based on the type of prosthesis used. Among the study cohort, 50 patients received a bioprosthetic valve, while 80 patients received a mechanical valve. We compared these groups in terms of perioperative characteristics and follow-up results. Statistical significance was determined using a p-value threshold of 0.05. Results There were no significant differences in age, gender, body mass index, or cardiac comorbidities between the two groups. Preoperative blood results and echo findings also showed no significant differences. Intraoperative characteristics and postoperative outcomes, including mortality and acute kidney injury, did not differ significantly between the groups. In addition, BHVG patients had shorter ICU stays compared to MHVG patients without significance. Conclusion Deliberate consideration is crucial when selecting valves for obese patients, particularly those with class II obesity. This is due to the potential influence of obesity on valve types, as well as the need to account for the possibility of bariatric surgery and its potential effects.

show abstract

Section: Metabolic Team Perspectivementioning

confidence: 99%

Section: Importance Of Bariatric Surgery In Patients With Obesity And...mentioning

confidence: 99%